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Abstract
During the DNA damage response (DDR), ubiquitination plays an important role in the recruitment and regulation of repair
proteins. However, little is known about elimination of the ubiquitination signal after repair is completed. Here we show
that the ubiquitin-specific protease 5 (USP5), a deubiquitinating enzyme, is involved in the elimination of the ubiquitin
signal from damaged sites and is required for efficient DNA double-strand break (DSB) repair. Depletion of USP5 sensitizes
cells to DNA damaging agents, produces DSBs, causes delayed disappearance of cH2AX foci after Bleocin treatment, and
influences DSB repair efficiency in the homologous recombination pathway but not in the non-homologous end joining
pathway. USP5 co-localizes to DSBs induced by laser micro-irradiation in a RAD18-dependent manner. Importantly,
polyubiquitin chains at sites of DNA damage remained for longer periods in USP5-depleted cells. Our results show that
disassembly of polyubiquitin chains by USP5 at sites of damage is important for efficient DSB repair.
Citation: Nakajima S, Lan L, Wei L, Hsieh C-L, Rapic´-Otrin V, et al. (2014) Ubiquitin-Specific Protease 5 Is Required for the Efficient Repair of DNA Double-Strand
Breaks. PLoS ONE 9(1): e84899. doi:10.1371/journal.pone.0084899
Editor: Arthur J. Lustig, Tulane University Health Sciences Center, United States of America
Received August 26, 2013; Accepted November 27, 2013; Published January 14, 2014
Copyright:  2014 Nakajima et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: UPCI shared resources that are supported in part by award P30CA047904 were used for this project. The project described was supported by the
National Institutes of Health through Grant Numbers UL1 RR024153 and UL1TR000005. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: san48@pitt.edu; lil64@pitt.edu
Introduction
DNA double-strand breaks (DSBs) are highly cytotoxic lesions
generated by ionizing radiation and various DNA damaging
agents. If they are not repaired or are repaired incorrectly, DSBs
cause cell death or chromosomal instability which eventually leads
to tumorigenesis or premature aging [1,2]. The major repair
pathways of DSBs in eukaryotic cells are the nonhomologous end-
joining (NHEJ) and the homologous recombination (HR) path-
ways. NHEJ is active throughout the cell cycle, while HR is
normally restricted to S and G2 cells because HR utilizes identical
sister chromatids for repair. Like repair pathways active with other
types of DNA damage, DSB repair requires the regulation of
proteins by post-translational modification [3]. Although many
proteins are post-translationally modified in DSB repair, a key
modification is that of core histones surrounding DNA damage
sites [4]. Although multiple histone modifications (phosphoryla-
tion, ubiquitination, sumoylation, methylation, acetylation) con-
tribute to efficient DSB repair [5], phosphorylation and ubiqui-
tination of core histones and sumoylation play the most important
roles in this repair [6-8]. Following DNA damage, ATM
phosphorylates the histone variant H2AX surrounding the
damage site [9]. Then, RNF8-UBC13 mediates the ubiquitination
of proteins at the damage site. RNF168-UBC13 recognizes the
RNF8-mediated ubiquitinated protein and ubiquitinates H2A-
type histones. RNF8-UBC13 extends the ubiquitination signal and
allows the formation of K63-linked polyubiquitin chains [10]. The
polyubiquitin chain is required for recruitment of downstream
checkpoint and repair factors, including RAP80/BRCA1, 53BP1,
and RAD18 [11]. In the process of conjugation of ubiquitin to a
target protein, ubiquitin E3 ligase is the most important player
because it confers substrate specificity and in most cases,
determines the extent of ubiquitination and the type of linkage.
Like other modifications, ubiquitination of a target protein is a
reversible reaction [12]. Ubiquitin modifications can be reversed
by the action of deubiquitinating enzymes (DUBs). DUBs are
ubiquitin-specific proteases that can remove the ubiquitin moiety
from a target protein by editing or disassembling the polyubiquitin
chain. DUBs are involved at several stages of the ubiquitination
process. By removing the polyubiquitin signal from target proteins,
DUBs can protect K48-linked polyubiquitin-conjugated proteins
from degradation by the proteasome [13,14]. DUBs also turn off a
signal induced by the monoubiquitination of target proteins
[15,16], and they are involved in disassembling ubiquitin chains to
regenerate free ubiquitin for re-use by the conjugation system.
Thus, the ubiquitination process is regulated by a cooperative
action of ubiquitin E3 ligases and DUBs.
Although the ubiquitination induced by DNA DSBs is well
known, little is known about how the ubiquitination signal is
eliminated from the damage sites. To gain further insight into the
deubiquitination process and its effects on DSB repair, we
investigated one of the DUBs. Here we show that USP5 (also
known as isopeptidase T; ISOT) is a novel factor functioning in
the repair of DSBs via HR. We also provide evidence suggesting
that the disassembly of free polyubiquitin chains at damage sites,
mediated by USP5, is necessary for efficient DSB repair.
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Materials and Methods
Cells and culture conditions
Flp-In T-REx 293 cells (Invitrogen) were used for expression of
FLAG-His-tagged USP5 or EGFP-tagged RAD18. HeLa cells
were used for survival, the cH2AX foci formation assay, and the
RAD51 foci formation assay with or without siUSP5 treatment.
RAD18-deficient human cells were derived from HCT116 as
previously described [17,18]. U2OS SceI cells were previously
described [19]. These cells were maintained in DMEM containing
10% of FBS with or without 1 mM of tetracycline for induction of
expression.
Plasmids
The human USP5 open reading frame was amplified by PCR
from a cDNA (Open Biosystems, MHS1011-60809) using PCR
primers with an Xho I site at the 59 terminus (USP5 59 Xho) and a
Not I site at the 39 terminus (USP5 39 Not) and cloned into
pBluescriptII. The identity of the cloned gene was confirmed by
sequencing. There are two known alternatively spliced forms of
USP5 which differ by an insertion of 23 amino acids. The
substrate specificity of the isoforms appears to be identical in vitro
[20]. We used transcription variant 2 (short isoform). Enhanced
green fluorescent protein (EGFP)-tagged USP5 was generated by
an in-frame ligation of a USP5 fragment (4–2505 nt) encoding the
entire USP5 sequence, except for the start and termination
codons, into either pEGFP-C1 or N1 (Clontech). To generate
USP5 deletion mutants, USP5 was amplified by PCR with the
primers. All of the constructs were confirmed by sequencing.
EGFP-tagged ubiquitin was generated as above. The pDsRed-
Monomer-RAD18 was previously described [17]. pCherry-TA
was derived from pCherry-TA-ER [19] but the ER domain was
removed.
Antibodies and siRNA
Anti-FLAG (M2; Sigma), anti-GFP (clones 7.1 and 13.1;
Roche), anti-USP5 (BC005139; Proteintech Group, Inc.), anti-
RAD18 (A301-304A; BETHYL), anti-ubiquitin FK1, FK2
(Cosmo Bio), anti-Rad51 (Cell Signaling), and anti-phospho
histone H2AX (Ser139) (Millipore) were used. A synthetic siRNA
duplex (D-006095-02, -03 and -04) for USP5 was purchased from
Dharmacon. The synthetic siRNA duplex (AM16708) for RAD18
was purchased from Ambion. Both siRNA duplexes were used
previously [21,22]. Ambion In Vivo Negative Control #1 siRNA
was used as a control siRNA. When we treated cells with the
transfection reagent but without adding siRNA for a control, we
indicated this as ‘‘-siRNA.’’ When we transfected the negative
control siRNA, we indicated this as ‘‘+siNC.’’
Survival assay
Cells were plated at 26105 cells per 60-mm Petri dish and
cultured overnight. Cells were transfected with or without 2 nM
siRNA for USP5 by using DharmaFECT (Thermo). After 3 days,
these cells were subjected to the survival assay. Cells were plated at
200 cells per 60-mm Petri dish and treated with methyl
methanesulfonate (MMS) (Sigma), Bleocin (Calbiochem), or
hydroxyurea (HU) (Sigma). Cells were cultured after treatment
for 12–14 days. Colonies were fixed and stained with 0.3% crystal
violet in methanol, and the number of colonies was counted.
Laser micro-irradiation
Laser micro-irradiation was performed as previously described
[19,23]. Briefly, cells were plated at 16105 cells per 35-mm glass
bottom dish (MatTek) and cultured at least overnight. For laser
micro-irradiation, cells were treated with or without 100 mM 8-
MOP for 10 min prior to irradiation with laser light of 405 nm,
which is not utilized by 8-MOP for cross-link formation, but has a
sensitizing effect on DNA [24]. The irradiation dose was 5 mW
(100%) for 10 or 100 ms at a single point irradiation. The same
dose was applied for 10 or 100 frames at a single line irradiation.
After irradiation, cells were incubated in medium for various
periods of time as indicated and then fixed and stained. For
analysis of deletion mutants of USP5, at least 33 cells were
irradiated and analyzed. After irradiation, we measured the
intensity of EGFP fluorescence at the irradiated area and
compared the intensity to that of the unirradiated area. We
defined it as a foci positive cell if the intensity of the irradiated area
is increased more than 1.2 fold compared to that of the
unirradiated area. The ATM inhibitor (KU-55933; Selleckchem)
was added for 2 hr prior to irradiation, and the final concentration
was 10 mM. The PARP inhibitor (Olaparib; Sigma) was added for
30 min prior to irradiation, and the final concentration was
10 mM.
Enzymatic production of DSBs at the restricted area of
cell nuclei
U2OS SceI cells were plated at 26105 cells per 35-mm glass-
bottom dish and cultured overnight. Cells were transfected with
pCMV-NLS-I-SceI and with or without USP5-EGFP and
incubated for 40 hr. Cells were fixed and stained by anti-cH2AX
antibody with or without anti-USP5 antibody. In the case of
endogenous USP5, three independent images were taken, and cell
nuclei which contained USP5 foci co-localized with cH2AX foci
were counted. At least 150 cells were counted in each sample.
cH2AX foci formation assay
Cells were plated at 26105 cells per 35-mm glass-bottom dish
and cultured overnight. Cells were transfected with or without
siUSP5 and incubated for 40 hr. Cells were treated with 5 mg/ml
Bleocin for 1 hr and incubated for the time indicated. The number
of cH2AX foci positive cell nuclei was counted after staining with
anti-phospho histone H2AX. We define a cell nucleus which
contains more than five cH2AX foci as a foci positive cell.
NHEJ and HR assays
NHEJ and HR assays were previously described [19]. Briefly, to
express I-SceI, pCMV-NLS-I-SceI was introduced by transfection,
using Lipofectamine 2000 reagent, into 1.5–36105 H1299 dA3-
1#1 cells (for NHEJ) [25] or 36105 HeLa pDR-GFP cells (for
HR) [26] pretransfected with siRNA for 48 hr using Lipofecta-
mine RNAiMAX (Invitrogen). siBRM for the NHEJ assay or
siBRCA1 for the HR assay was used as a positive control [25].
EGFP-positive cells were counted with Cellquest software. For
FACS analysis, cells were harvested by trypsinization, washed with
PBS, stained, and applied on the FACS caliber apparatus (Becton
Dickinson).
RAD51 foci formation assay
HeLa cells were plated at 16105 cells per 35-mm glass-bottom
dish and cultured overnight. Cells were transfected with or without
siUSP5-03 or -04 and incubated for 48 hr. Cells were treated with
X-ray from a 137Cs source with total doses of 5 Gy (fluxes of
0.68 Gy/min) and incubated for the time indicated. RAD51 foci
positive cells were counted in 50 cells in each of three different
areas. We define a cell nucleus which contains more than three
RAD51 foci as a foci positive cell.
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Primers
To generate USP5 expression constructs, USP5 was amplified
by PCR with the following primers:
USP5 59 Xho: TTT TCT CGA GGC GGA GCT GAG TGA
GGA GGC GCT G; USP5 39 Not: TTT TGC GGC CGC AGC
TGG CCA CTC TCT GGT AGA AGT; USP5 59 Xho 571:
TTT TCT CGA GCG AAT CCC TCC CTG TGG CTG GAA
G; USP5 59 Xho 817: TTT TCT CGA GGC TGA GCA CCT
GTC CCA CTT CGG C; USP5 59 Xho 2089: TTT TCT CGA
GGC CGA CCC CCC TCC TGA GGA CTG T; USP5 39 Not
594: TTT TGC GGC CGC ACT TCC AGC CAC AGG GAG
GGA TTC G; USP5 39 Not 840: TTT TGC GGC CGC AGC
CGA AGT GGG ACA GGT GCT CAG C; USP5 39 Not 2112:
TTT TGC GGC CGC AAC AGT CCT CAG GAG GGG GGT
CGG C.
Immunofluorescence
After irradiation, cells were incubated in medium for the
indicated time and then washed twice with PBS and fixed with
methanol-acetone (1:1) for 10 min at 220uC. The fixed cells were
dried, then rinsed once with PBS-T (0.05% Tween 20 in PBS), and
incubated in 5% BSA in PBS-T for 30 min at room temperature.
Cells were then incubated with antibody for more than 1 hr. Cells
were washed 3 times with PBS-T and incubated with a second
antibody conjugated with Alexa Fluor (Molecular Probes) for more
than 30 min. Cells were washed 3 times with PBS-T and then
mounted in drops of VECTASHIELD Mounting Medium with
DAPI (Vector Laboratories).
Results
USP5 responds to DNA DSBs
USP5 is one of the DUBs and it disassembles unanchored
polyubiquitin chains by a sequential exo mechanism [27]. To
investigate whether USP5 is involved in the DDR, we analyzed the
response of EGFP-tagged USP5 to DNA DSBs. Here, we found
that EGFP-tagged USP5 co-localized to laser micro-irradiation
sites (Figure 1A). The C-terminus fusion of USP5 (USP5-EGFP)
co-localized to sites of DNA damage induced by laser micro-
irradiation, while the N-terminus fusion of USP5 (EGFP-USP5)
did not co-localize. The radiation dose is relatively high enough to
produce DNA DSBs, suggesting that USP5 may co-localize with
DSBs. To confirm that USP5 co-localizes to DNA DSBs, we used
another cell line, U2OS SceI (Figure S1 in File S1) [19]. U2OS
SceI cells harbor a stable 200 copy transgene array of a plasmid
containing the restriction site for I-SceI adjacent to a 96 repeat
array of tetracycline-response-elements (TREs). If we express I-
SceI endonuclease, DSBs are induced enzymatically at the
restricted area of cell nuclei which co-localizes a Cherry-TA
focus. As shown in Figure 1B, the USP5-EGFP focus was clearly
detected if I-SceI endonuclease was introduced simultaneously,
although we could not detect USP5 foci that co-localized to
cH2AX (a marker of DSBs) foci after Bleocin treatment. Next, to
determine whether endogenous USP5 also responds to DSBs, we
investigated the damage response of endogenous USP5 by using
anti-USP5 antibody (Figure 1C). Without expression of I-SceI
endonuclease, we could not detect USP5 foci (Figure 1C, upper
panel). However, with expression of I-SceI endonuclease, we
clearly detected USP5 foci that co-localized to cH2AX foci
(Figure 1C, lower panel). About 80% of cH2AX foci co-localized
to USP5 foci (Figure 1C, left). These data indicate that USP5
responds to DSBs.
We counted foci positive cells at 5 min and 10 min after
irradiation. About 80% of the cells were foci positive at 5 min after
irradiation (Figure 1C, left panel). Foci positive cells gradually
decreased to about 15% at 10 min after irradiation. To investigate
whether the damage response of USP5 depends on ATM activity,
we examined the damage response of USP5 with the ATM
inhibitor, KU-55933. Although the frequency of cH2AX foci
positive cells after Bleocin treatment was clearly decreased by
treatment with KU-55933 (Figure S2 in File S1), the frequency of
USP5-EGFP foci positive cells at 5 min after laser irradiation with
treatment of KU-55933 was almost the same as that of foci
positive cells without treatment with KU-55933 (Figure 1C, right
panel). The frequency of USP5-EGFP foci positive cells slightly
increased at 10 min after irradiation in the presence of KU-55933.
The delayed disappearance may be caused by the inhibition of
DSB repair in the presence of the ATM inhibitor. The data
indicate that the damage response of USP5 does not depend on
ATM activity. Since many repair proteins co-localize to DNA
damage in a PARP-dependent manner [28], we also examined the
influence of the PARP inhibitor, Olaparib (AZD2281,
KU0059436). However, the damage response of USP5 was not
affected by the PARP inhibitor (Figure S3 in File S1).
To determine which domain of USP5 is required for co-
localization of USP5 with DSBs, we examined co-localization of
deletion mutants with DSBs. Although the C mutant co-localized
with DSBs slightly, the co-localizations are weak and the frequency
is low compared to that of full length USP5. Only the full length
USP5 co-localizes with DSBs stably and strongly (Figure 1D). We
conclude that full length USP5 is required for efficient co-
localization with DSBs induced by laser micro-irradiation.
We also examined the damage response of USP5 to different
types of damage, UV-induced DNA damage [29,30] or single
strand breaks induced by UV damage endonuclease and UV
irradiation [31]. We did not detect co-localization of USP5 to
either type of DNA damage.
USP5 is necessary for cell survival after DNA damage
To investigate whether USP5 is required for DNA repair, we
examined cell survival in USP5-depleted cells after treatment with
various DNA damaging reagents. siUSP5 suppressed USP5
expression to about 10% of control (Figure 2A), and this treatment
sensitized cells to Bleocin, hydroxyurea (HU), and methyl-
methanesulfonate (MMS) significantly (Figure 2B). Thus, USP5
is necessary for cell survival after DNA damage. Although
depletion of USP5 sensitized cells to DNA damaging agents, the
effect is relatively mild. Since we considered that this mild effect
was caused by insufficient and/or temporary suppression of USP5
by siRNA, we tried to establish a constitutive cell line using
shRNA. Although we identified several clones whose expression of
USP5 was suppressed, the effect of suppression was reduced
during culture and the expression level of USP5 reached a normal
level. Constitutive suppression of USP5 may not be achieved in the
cell because of collapse of the ubiquitin system.
USP5 knockdown causes the delayed disappearance of
cH2AX foci
USP5-depleted cells showed sensitivity to the DNA damage
reagents, which are producing DSBs directly or indirectly, and
USP5 co-localizes to DSBs after laser micro-irradiation, suggesting
that USP5 may play a role in DSB repair. To investigate whether
USP5 is required for DSB repair, we monitored the appearance
and disappearance of cH2AX foci after Bleocin treatment with or
without siUSP5 treatment (Figure 3A). Without Bleocin treatment
or with the treatment at 0.5 hr or 4 hr post-incubation, there were
no significant differences with or without siUSP5 treatment. This
indicates that USP5 is not required for the maintenance of the
USP5 Is Required for Efficient DSB Repair
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steady state level of cH2AX foci or the production of cH2AX foci
after DNA damage. In control cells, the number of cH2AX foci
positive cells decreased at 24 hr and 48 hr post incubation,
showing that DSBs are repaired in these cells. However, USP5-
depleted cells delayed the disappearance of cH2AX foci signifi-
cantly at 24 hr and 48 hr post-incubation. In these cells, DSBs are
not repaired efficiently. Thus, USP5 is required for efficient DSB
repair.
Depletion of USP5 influences HR but not NHEJ
DNA DSBs are repaired by two different pathways in human
cells, HR and NHEJ. To investigate which pathway USP5 is
involved in, we analyzed HR and NHEJ frequencies by using
reporter assays (Figure 3B) [25,26]. Although it is not comparable
to the effects caused by BRCA1 depletion (,40%), depletion of
USP5 expression reduced the percentage of GFP-positive cells to
less than 80% as compared with control cells in the HR assay
(Figure 3B, left panel). However, depletion of USP5 expression did
not reduce the percentage of GFP-positive cells at all in the NHEJ
assay (Figure 3B, right panel). These data indicate that USP5 is
involved in the repair of DSBs via the HR pathway but not the
NHEJ pathway. It is known that the repair frequency of HR
depends on cell cycle stages. siUSP5 treatment may affect normal
cell cycle progression and cause the suppression of HR. To
exclude this possibility, we analyzed cell cycle progression after
siUSP5 treatment by FACS, finding that siUSP5 treatment does
not affect the distribution of cells in different cell cycle stages
compared to control (Figure S4 in File S1). To exclude another
Figure 1. USP5 co-localizes with DNA DSBs. A: EGFP-tagged USP5 was expressed in HeLa cells, and cells were irradiated with the laser at a dose
of 100 frames with 100 mM of 8-MOP. 8-MOP sensitizes laser light to produce DNA base damage and strand breaks. B: EGFP-tagged USP5 co-localizes
with DNA DSBs produced by a restriction enzyme. Plasmid DNAs for expression of USP5-EGFP and Cherry-TA were introduced in U2OS SceI cells with
or without NLS-SceI expression plasmid DNA by Lipofect amine 2000. After overnight incubation, cells were fixed and stained by anti-cH2AX
antibody. C: Endogenous USP5 co-localizes with DNA DSBs produced by a restriction enzyme. Plasmid DNA for expression of NLS-SceI was
introduced in U2OS SceI cells by Lipofect amine 2000. After overnight incubation, cells were fixed and stained by anti-USP5 antibody and anti-cH2AX
antibody. At least 150 cells were counted in each sample. D: Damage response of USP5-EGFP after laser micro-irradiation with or without ATM
inhibitor. Cells were irradiated with the laser at a dose of 100 frames with 100 mM of 8-MOP and with or without 10 mM of ATM inhibitor. The results
are averages obtained from two independent experiments, and more than 52 cells were irradiated and analyzed for the damage response. E: Domain
analysis of USP5 with regard to the damage response. Schematic presentation of domains in USP5 and the GFP-tagged mutant constructs. zf-UBP,
Zinc-finger in ubiquitin-hydrolases and other proteins; UBA, Ubiquitin Associated domain. EGFP-tagged USP5 full length or deletion mutant was
expressed in HeLa cells, and cells were irradiated with the laser at a dose of 100 frames with 100 mM of 8-MOP. The results are averages obtained from
at least two independent experiments and more than 33 cells were irradiated and analyzed.
doi:10.1371/journal.pone.0084899.g001
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possibility, that the defect of HR is caused by siRNA treatment
itself or off-target effects from use of only one single USP5 siRNA
(siUSP5-02), we confirmed the effect of the negative control
siRNA (siNC) or two independent siRNAs targeting USP5
(siUSP5-03, -04) on cell survival or the HR assay (Figure S5 in
File S1). Although siUSP5-04 treatment showed a relatively severe
phenotype, three independent siRNA treatments caused an almost
similar phenotype. We also checked the expression level of RAD51
because RAD51 is easily affected by the off-target effects [32].
There are no significant differences in the expression level of
RAD51 in siRNA-treated cells. These data suggest that the defect
of HR is not caused by the off-target effects of siRNA treatment.
Depletion of USP5 influences the disappearance of
RAD51 foci after X-ray irradiation
Since depletion of USP5 influences HR, we investigated the
disappearance of RAD51 foci after X-ray irradiation with or
without siUSP5 treatment (Figure 3C). Depletion of USP5 does
not affect the number of RAD51 foci in the cells analyzed 1 hr or
4 hr after X-ray treatment, suggesting that USP5 is not required
for the production of RAD51 foci after DNA damage. The
number of RAD51 foci positive cells without siRNA treatment
decreased at 24 hr post-incubation compared to 4 hr post-
incubation, while USP5-depleted cells delayed the disappearance
of RAD51 foci significantly at 24 hr post-incubation. These data
support the conclusion that USP5 plays an important role in HR.
USP5 is required for rapid dissociation of ubiquitin at
sites of DSBs
Since many proteins are monoubiquitinated or polyubiquiti-
nated at sites of DSBs, we speculated that the role of USP5 at sites
of damage is to eliminate polyubiquitin chains induced by DSBs.
To investigate whether depletion of USP5 affects the kinetics of
ubiquitin at sites of damage, we expressed EGFP-tagged ubiquitin
(EGFP-Ub) in cells and irradiated the cells with the laser. In
control cells, EGFP-Ub co-localized with damage immediately,
reaching a peak around 10 min after irradiation and then
dissociating from damage sites gradually (Figure 4A, blue line).
In USP5-depleted cells, EGFP-Ub co-localized with damage
immediately as in control cells but did not dissociate from damage
sites even 30 min after irradiation (Figure 4A, red line). These data
indicate that depletion of USP5 delays dissociation of ubiquitin
from damage sites but does not affect the recruitment of ubiquitin
to damage sites. However, it is impossible to distinguish between
monoubiquitination and polyubiquitination by this method. To
determine whether the increased signal is caused by accumulation
of a monoubiquitinated protein or a polyubiquitin chain, we used
a ubiquitin antibody, FK1, which recognizes the polyubiquitin
chain but not monoubiquitinated protein or free ubiquitin.
Although the signal of polyubiquitination is very faint without
siUSP5 treatment, we detected the signal at damage sites at 5 min
after irradiation (Figure 4B, left panel). At 30 min after irradiation,
the signal was not detected at damage sites. In contrast, the signal
of polyubiquitination was detected even at 30 min after irradiation
with siUSP5 treatment. These data are well correlated with the
data obtained by EGFP-Ub. We also used another ubiquitin
antibody, FK2, which recognizes both polyubiquitin chains and
monoubiquitinated proteins. There is no significant difference
among signals detected by FK2 (Figure 4B, right panel). Since the
preferred substrate for USP5 is an unanchored polyubiquitin
chain, in other words, the free polyubiquitin chain [27,33,34], it is
plausible that the increased signal obtained by FK1 antibody in
USP5-depleted cells is caused by accumulation of free polyubi-
quitin chains at sites of damage. Thus, USP5 is apparently
required for the rapid elimination of free polyubiquitin chains
from damage sites.
Figure 2. USP5 is necessary for cell survival after DNA damage. A: Knockdown of USP5 expression by siUSP5 treatment. B: Colony forming
assay after treatment with Bleocin, hydroxyurea, or methyl-methanesulfonate, with or without siUSP5 treatment. Filled square indicates without
siUSP5 treatment and filled circle indicates with siUSP5 treatment; error bars, 6 SED. The P-value was calculated using Student’s t-test.
doi:10.1371/journal.pone.0084899.g002
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USP5 interacts with RAD18
Some DUBs appear to function with high specificity toward one
or several substrates, but there are only a few examples of this
specificity. The functional specialization of DUBs is associated
with their residence in specific protein complexes [35]. DUBs and
E3 are often found in a complex together [36,37]. Although we
showed that full length USP5 co-localized with DNA damage
induced by laser micro-irradiation, there is no domain that is
known to have the specific ability to respond to DNA damage in
USP5, like a BRCT domain or zinc-finger domain [3]. From the
above facts and results, we speculated that the E3 ligase complex
or another protein involved in DSB repair might recruit USP5 to
sites of damage. We investigated the interaction between USP5
and several E2–E3 ligase complexes that are known to be involved
in DSB repair by pull-down experiments between USP5 and
RNF168, UBC13, BRCA1, and RAD18. Among these E2–E3
ligase complexes, we found that USP5 interacts with RAD18.
RAD18 is highly conserved from yeast to human and plays a
major role in post-replication repair (PRR). RAD18 interacts with
HHR6A, B (E2) and Pol eta (translesion polymerase) and regulates
the polymerase switch via monoubiquitination of PCNA [38,39].
In vertebrates, RAD18 has another role besides PRR [40].
RAD18 is also involved in DSB repair via the HR pathway and
recruits RAD51C to DSBs [41]. We transiently expressed EGFP-
tagged RAD18 in cells expressing FLAG-His-tagged USP5 and
pulled it down by the His-tag. EGFP-tagged RAD18 was
significantly pulled down in the cells expressing FLAG-His-tagged
USP5 (Figure 5A). Next, to confirm the interaction, we checked
the binding between EGFP-tagged RAD18 and endogenous
USP5. We detected a clear interaction when EGFP-RAD18 was
pulled down, and the pull downs were detected by anti-USP5
antibody only in the presence of Bleocin treatment (Figure 5B).
This data indicates that USP5 interacts with RAD18 in the
presence of DNA damage.
Figure 3. USP5 is required for double strand break repair via the homologous recombination pathway. A: USP5 knockdown affects the
disappearance of cH2AX foci. The number of nuclei which contain more than 5 cH2AX foci was counted and summarized in the graph. Blue bar
indicates without siUSP5 treatment and red bar indicates with siUSP5 treatment; error bars, 6 SED. The P-value was calculated using Student’s t-test.
Representative figures for cH2AX foci after Bleocin treatment in the presence and absence of siUSP5 are shown at the left. B: NHEJ and HR
frequencies in cells depleted of USP5. Results of western blot analysis after siRNA treatment are shown at the left. Assay for NHEJ of chromosomal
DSBs in H1299 cells or assay for HR frequency of chromosomal DNA containing a recombination substrate DR-GFP in HeLa cells. The GFP-positive cell
fraction in cells depleted of USP5 was determined and compared with that in cells treated with siCont or siBRM for the NHEJ assay or siBRCA1 for the
HR assay for determination of frequencies; error bars, 6 SED. The P-value was calculated using Student’s t-test. C: USP5 knockdown affects the
disappearance of RAD51 foci. Representative figures for RAD51 foci after 5 Gy X-ray irradiation in the presence and absence of siUSP5 are shown at
the top. The number of nuclei which contain more than three RAD51 foci was counted and summarized in the graph.
doi:10.1371/journal.pone.0084899.g003
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RAD18 recruits USP5 to DSBs
To investigate whether RAD18 is required for co-localization of
USP5 with DSBs, we analyzed the damage response of USP5 after
laser micro-irradiation in RAD18-proficient or -deficient cells.
Although co-localization of USP5 is observed clearly in RAD18-
proficient cells, co-localization of USP5 is significantly reduced in
RAD18-deficient cells (Figure 5C, left panel). This data indicates
that efficient co-localization of USP5 to DSBs depends on RAD18.
We have previously shown that RAD18 responds to UV-induced
lesions and DNA strand breaks independent of DNA replication,
and this ability depends on the zinc-finger domain of RAD18 [17].
Other groups also have shown that the zinc-finger domain of
RAD18 binds to polyubiquitin chains [42] and RAD18 recruits to
DSBs in a zinc-finger domain dependent manner [41]. The
middle part of RAD18 contains another damage responsive
domain, the SAP domain, in addition to the zinc-finger domain.
The SAP domain is responsible for recruitment to stalled
replication forks [17,43]. To investigate further, we transiently
co-expressed EGFP-tagged USP5 and DsRed-tagged RAD18 WT
or mutants in RAD18-deficient cells and examined co-localization
of USP5 after laser micro-irradiation (Figure 5C, right panel).
Expression of the DsRed vector alone did not result in co-
localization of USP5 with DSBs in RAD18-deficient cells, while
expression of DsRed fused to RAD18 WT clearly resulted in co-
localization of USP5 with DSBs (Figure 5C, right panel). The zinc-
finger mutant of RAD18 (RAD18 CF) does not co-localize with
DSBs, and expression of the zinc-finger mutant does not result in
co-localization of USP5 with DSBs. On the other hand, the SAP
domain deletion mutant (RAD18 DSAP) co-localizes with DSBs,
and expression of the SAP domain deletion mutant results in co-
localization of USP5 with DSBs. As expected, the double mutant
(RAD18 CF DSAP) does not co-localize with DSBs, and
expression of the double mutant does not result in co-localization
of USP5. These data indicate that co-localization of USP5 with
DSBs depends on RAD18 and its zinc-finger domain.
USP5 plays a role in the same pathway as RAD18 to
repair DSBs
Since efficient co-localization of USP5 with DSBs depends on
the damage response of RAD18, we speculated that USP5 plays a
role in the same pathway as RAD18 to repair DSBs. To
investigate whether USP5 is required in the same pathway as
RAD18, we analyzed HR frequencies depleted of USP5 and/or
RAD18 (Figure 5D). Depletion of RAD18 expression reduced the
significant percentage of GFP-positive cells to less than 60% of
control cells in the HR assay. Although there may be a slight
difference between the effects caused by RAD18 depletion (,60%)
and USP5 depletion (,80%), the difference is not significant.
Depletion of both expressions did not further reduce the
percentage of GFP-positive cells, indicating that there is no
Figure 4. USP5 is required for disassembly of polyubiquitin chains at sites of DNA damage. A: EGFP-tagged ubiquitin was expressed in
HeLa cells with or without siUSP5 treatment. Cells were irradiated with the laser light for 100 ms. The intensity of EGFP-Ub at the irradiated site was
analyzed and summarized in the graph. The results are averages obtained from three independent experiments (n = 5). B: Cells were irradiated with
the laser for 10 frames with 100 mM of 8-MOP and then fixed and stained by anti-ubiquitin antibody (FK1; left panel, FK2; right panel) and anti-RAD18
antibody. Anti-RAD18 antibody is used for showing irradiated sites.
doi:10.1371/journal.pone.0084899.g004
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additive effect of depletion by siUSP5 and siRAD18 on HR
frequency. Thus, the data suggest that USP5 belongs to the same
epistasis group as RAD18 in DSB repair.
Discussion
Ubiquitination of proteins surrounding a DSB is one of the key
steps in DSB repair and many proteins are mono- or poly-
ubiquitinated near the sites of DSBs. While it is well known that
several E3 ligases are involved in the ubiquitination of proteins
associated with DSBs, little is known about the mechanism that
removes the mono- or polyubiquitin from proteins at damage sites.
We found that USP5 is a novel player involved in efficient HR
repair. USP5 is one of a number of DUBs which have been studied
well; the activity of USP5 concerning substrate specificity and
kinetics is well understood [27,33,34]. However, the role of USP5
in DNA repair is not known. We found that depletion of USP5
results in increased sensitivity to DNA damaging agents (Figure 2B)
and the delayed disappearance of cH2AX foci (Figure 3A), and
this defect is associated with an impairment of HR (Figure 3B, C).
These data suggest that USP5 plays a role in DSB repair via the
HR pathway.
There is accumulating evidence that ubiquitination-mediated
protein degradation at sites of damage, and recruitment of
proteasomes to damage sites, are important for efficient DSB
repair. A recent paper has shown that the SUMO-targeted
Figure 5. USP5 interacts with RAD18 and USP5 depends on RAD18 in DSB repair. A: Interaction between expressed proteins. We
transiently expressed EGFP-tagged RAD18 in cells expressing FLAG-His-tagged USP5 and pulled down by the His-tag and pull downs were detected
with anti-GFP antibody. B: Interaction between EGFP-tagged RAD18 and endogenous USP5. Cells were treated with or without Bleocin for 2 hr and
then cells were extracted. Extracts were pulled down with anti-GFP antibody and detected by anti-USP5 antibody. C: Damage response of USP5-EGFP
after laser micro-irradiation in RAD18-proficient or -deficient cells. EGFP-tagged USP5 and DsRed-tagged RAD18 WT or each mutant were co-
expressed in RAD18-deficient cells, and the damage response after laser micro-irradiation was analyzed. Cells were irradiated with the laser light for
100 ms. D: HR frequencies in cells depleted of USP5 and/or RAD18. Results of western blot analysis after siRNA treatment are shown on the top. The
GFP-positive cell fraction in cells depleted of USP5 and/or RAD18 was determined and compared with that in cells treated with siCont or siBRCA1 for
determination of frequencies; error bars, 6 SED. The P-value was calculated using Student’s t-test.
doi:10.1371/journal.pone.0084899.g005
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ubiquitin E3 ligase, RNF4, is required for turnover of MDC1 and
RPA1, and promotes DSB repair [44]. Another paper has shown
that JMJD2A is a novel substrate of RNF8 and RNF168 for
ubiquitination after DNA damage, and recruitment of 53BP1 to
sites of DNA damage depends on degradation of JMJD2A [45].
These results indicate that degradation of proteins induced by
ubiquitination at sites of damage is important for DSB repair.
Moreover, several papers have shown that some components of
the 26S proteasome are recruited to sites of damage and
proteasome activity is required for efficient DSB repair [44,46].
As shown in Figure 3, we found that USP5 is recruited to DSBs
immediately after they are formed, and the recruitment depends
on RAD18 (Figure 5). Moreover, we found that USP5 is required
for rapid elimination of the polyubiquitin chain at sites of damage
(Figure 4). These data suggest that USP5 also plays a role in
regulating protein degradation at sites of damage by disassembling
free polyubiquitin chains.
Depletion of USP5 only affected the frequency of HR repair but
not NHEJ in DSB repair (Figure 3B). The mechanism of HR is
more complicated than that of NHEJ. HR utilizes an identical
sister chromatid as a template for accurate repair, while NHEJ
connects broken ends directly. It is known that many repair
proteins involved in HR form ionized radiation-induced foci
(IRIF), indicating that a large number of molecules accumulate at
one DSB [47]. In contrast, repair proteins involved only in NHEJ,
such as DNA-PKcs, KU70/80, and XRCC4/LIG4, do not form
IRIF, and detection of co-localization of these repair proteins with
DSBs requires a large number of DSBs in a restricted area using
laser micro-irradiation or I-SceI expression plus high copy number
I-SceI recognition sites in the genome [19,48,49]. This fact
indicates that a relatively low number of molecules are required for
the repair of one DSB in the NHEJ pathway compared to HR.
The turnover of protein at sites of damage may be more important
in the HR pathway than the NHEJ pathway. Therefore, depletion
of USP5 only affected the frequency of HR. However, DUBs other
than USP5 might be required for the efficient repair of DSBs in
the NHEJ pathway.
We showed that USP5 is required for rapid elimination of the
polyubiquitin chains at sites of damage (Figure 4), and we
considered the mechanisms by which polyubiquitin chains
accumulate at sites of DNA damage in the absence of USP5.
Although USP5 has high activity in disassembling free poly-
ubiquitin chains from their free C-terminus end regardless of the
linkage type of polyubiquitination, USP5 has almost no activity in
cutting the bond between substrate protein and the C-terminus of
ubiquitin [27,34]. In order for USP5 to work, other DUB(s) must
remove a polyubiquitin chain from the substrate protein. In
humans, 3 DUBs associate with the 26S proteasome: POH1/
RPN11, USP14, and UCH37 [35]. In order to recycle ubiquitin
molecules, the polyubiquitin chain is removed before proteins are
processed by proteasomes [50]. USP14 and UCH37 appear to
antagonize degradation by removing the polyubiquitin chain from
the substrate protein through cutting at the distal tip of the chain,
whereas POH1/RPN11 appears to promote substrate degradation
by cutting at the base of the chain to release the chain en bloc [35].
USP5 disassembles this free polyubiquitin chain efficiently.
Recently, it has been shown that POH1/RPN11 is required for
a DSB response [51]. Another possibility is that some DUBs
remove polyubiquitin chains from substrate proteins without
disassembly of the chains. It is known that several DUBs are
involved in DSB repair. For example, USP11 and USP3
antagonize RNF8-mediated ubiquitination [52–54], and the
USP1/UFA complex promotes DSB repair via HR [55]. The
role of USP5 may then be to eliminate the free polyubiquitin
chains from sites of DSBs.
Depletion of USP5 causes the accumulation of polyubiquitin
chains at sites of damage, and this inhibits the efficient repair of
DSBs (Figures 3, 4). This result suggests that polyubiquitin chains
must be removed rapidly from damage sites. It is known that
accumulation of polyubiquitin chains inhibits the proteasome
activity by a competing mechanism in yeast and human cells
[22,56]. Accumulation of polyubiquitin chains at sites of damage
may delay the turnover of proteins which should be degraded for
proper progression of DSB repair. Another possibility is that free
polyubiquitin chains recruit other repair proteins or retain repair
proteins which have a ubiquitin-binding motif. This may inhibit
progression of the repair process or the next round of repair. This
may also explain why the depletion of USP5 has only a mild effect
on survival and HR because USP5 controls protein degradation
through the ubiquitin system but not the HR mechanism directly.
From the above results and facts, we propose the following
model. After production of DSBs, many proteins surrounding
damage sites, including core histones, are mono- or polyubiqui-
tinated. This ubiquitination signal recruits many repair proteins.
USP5 is also recruited to sites of DNA damage in a RAD18-
dependent manner. During the repair process or after completion
of repair, polyubiquitinated proteins are degraded by the
proteasome. Alternatively, polyubiquitin chains are removed by
some DUBs without disassembly. This causes accumulation of free
polyubiquitin chains at sites of damage. The accumulation of
polyubiquitin chains inhibits turnover of proteins at the sites of
damage, and this may inhibit proper progression of the repair
process or the next round of repair. Thus, USP5 is required for the
efficient repair of DSBs by disassembling free polyubiquitin chains
at sites of damage.
There are approximately 95 putative DUBs in human cells,
whereas there are more than 600 putative E3 ligases, indicating
the low substrate specificity of DUBs compared to E3 ligases
[36,57]. The functional specialization of DUBs often reflects their
residence in specific protein complexes [35]. The action of USP5 is
the disassembly of free polyubiquitin chains. This activity is
general rather than the removal of ubiquitin from specific
substrate proteins. However, by binding to RAD18, which
recognizes polyubiquitin chains, USP5 is recruited to sites of
damage and plays a role in DSB repair, disassembling poly-
ubiquitin chains at the sites of damage. Our results suggest how the
ubiquitination process is regulated by protein-protein interactions
to confer specific roles to a relatively small number of DUBs.
Supporting Information
File S1 Figures S1–S5. Figure S1. U2OS I-SceI system for
inducing DSB in a single cell; Enzymatic production of DSB at a
restricted area of the nucleus. An I-SceI site was inserted next to
96 repeats of TRE. The length of an I-SceI site is 18 base pairs
and there is no I-SceI site in the human genome. We introduced
this construct into a U2OS cell and selected a clone which has
more than 200 copies of the construct in its genome at only one
position. To show the position where this construct is inserted,
Cherry-TA (Cherry is a red fluorescent protein) and TA (a trans-
activator which binds to TRE) were used. When we express
Cherry-TA, the spot which shows the position of the construct is
detected as a red focus. With expression of I-SceI, a cH2AX focus
colocalized with a Cherry focus is detected. With expression of I-
SceI and a GFP-tagged repair protein, Ku80, a GFP-Ku80 focus
colocalized with a Cherry focus is detected. Figure S2. Treatment
with an ATM inhibitor affects the foci formation of cH2AX after
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bleocin treatment. A: Cells were treated with 5 mg/ml of bleocin
for 1 hr with or without the ATM inhibitor, KU-55933, and then
cells were washed twice and fresh medium was added with or
without KU-55933. After incubation for 2 hr, cells were fixed and
stained with anti-phospho histone H2AX. Representative data are
shown. B: % of cH2AX foci positive cells was summarized in the
graph. The number of cell nuclei which contain more than five
cH2AX foci was counted as foci positive cells. In each condition,
more than 300 cells were counted. Figure S3. Treatment with the
PARP inhibitor, Olaparib, does not affect the damage response of
USP5 after laser irradiation. Percent of USP5-EGFP foci positive
cells at 5 min after irradiation was summarized in the graph. The
result was obtained in two independent experiments and more
than 50 cells were irradiated and analyzed. Figure S4. siUSP5
treatment does not affect cell cycle progression. Cells were treated
with or without siUSP5. After 3 days, cells were fixed with 70%
ethanol and stained by PI (Propidium iodide) and then analyzed
with a C6 Flow Cytometer (Accuri Cytometers, Inc.). For a
positive control, cells were treated with HU (1 mM) or nocodazole
(100 mg/ml) for 24 hr before collection. The results are summa-
rized in the graph. Figure S5. Treatment of different siRNAs
targeted for USP5 show a similar phenotype. A: Survival assay.
HeLa cells were plated at 16105 cells per well of 6 well-plates and
cultured overnight. Cells were transfected with negative control
siRNA (siNC) or 2 nM siRNA for USP5 (siUSP5-02, -03 or -04)
by using DharmaFECT (Thermo). After 2 days these cells were
subjected to the survival assay. Cells were plated at 200 cells per
60-mm Petri dish and treated with Bleocin or methyl methane-
sulfonate (MMS). Cells were cultured after treatment for 11 days.
Colonies were fixed and stained with 0.3% crystal violet in
methanol, and the number of colonies was counted. The averages
and SEDs were obtained from three dishes at each point. The
error bars indicate 6 SED. The P-value was calculated using
Student’s t-test. Results of western blot analysis after siRNA
treatment are shown at the top. B: HR assay. DR-GFP cells were
plated at 16105 cells per well of 6 well-plates and cultured
overnight. Cells were transfected with negative control siRNA
(siNC) or 2 nM siRNA for USP5 (siUSP5-02, -03 or -04) by using
DharmaFECT. After overnight incubation, these cells were
transfected with pCMV-NLS-I-SceI by Lipofectamin 2000 (Life
Technologies). After 2 days these cells subjected to FACS analysis
(BD Accuri C6; BD Biosciences). The averages and SEDs were
obtained from three independent experiments. The error bars
indicate 6 SED. The P-value was calculated using Student’s t-test.
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